Differential regulation of mature and precursor microRNA expression by NMDA and metabotropic glutamate receptor activation during LTP in the adult dentate gyrus in vivo.
Regulation of microRNA (miRNA) expression and function in the context of activity-dependent synaptic plasticity in the adult brain is little understood. Here, we examined miRNA expression during long-term potentiation (LTP) in the dentate gyrus of adult anesthetized rats. Microarray expression profiling identified a subpopulation of regulated mature miRNAs 2 h after the induction of LTP by high-frequency stimulation (HFS) of the medial perforant pathway. Real-time polymerase chain reaction analysis confirmed modest upregulation of miR-132 and miR-212, and downregulation of miR-219, while no changes occurred at 10 min post-HFS. Surprisingly, pharmacological blockade of N-methyl-d-aspartate receptor (NMDAR)-dependent LTP enhanced expression of these mature miRNAs. This HFS-evoked expression was abolished by local infusion of the group 1 metabotropic glutamate receptor (mGluR) antagonist, (RS)-1-aminoindan-1,5-dicarboxylic acid (AIDA). AIDA had no effect on LTP induction or maintenance, but blocked activity-dependent depotentiation of LTP. Turning to the analysis of miRNA precursors, we show that HFS elicits 50-fold elevations of primary (pri) and precursor (pre) miR-132/212 that is transcription dependent and mGluR dependent, but insensitive to NMDAR blockade. Primary miR-219 expression was unchanged during LTP. In situ hybridization showed upregulation of the pri-miR-132/212 cluster restricted to dentate granule cell somata. Thus, HFS induces transcription miR-132/212 that is mGluR dependent and functionally correlated with depotentiation rather than LTP. In contrast, NMDAR activation selectively downregulates mature miR-132, -212 and -219 levels, indicating accelerated decay of these mature miRNAs. This study demonstrates differential regulation of primary and mature miRNA expression by mGluR and NMDAR signaling following LTP induction, the function of which remains to be defined.
Wibrand
Karin
K
Department of Biomedicine and Bergen Mental Health Research Center, University of Bergen, Jonas Lies vei 91, N-5009 Bergen, Norway.
Panja
Debabrata
D
Tiron
Adrian
A
Ofte
May L
ML
Skaftnesmo
Kai-O
KO
Lee
Cherin S
CS
Pena
John T G
JT
Tuschl
Thomas
T
Bramham
Clive R
CR
D000818:Animals; D003609:Dactinomycin / Q000494:pharmacology; D018891:Dentate Gyrus / Q000378:metabolism* / Q000502:physiology; D005786:Gene Expression Regulation / Q000187:drug effects / Q000502:physiology*; D007189:Indans / Q000494:pharmacology; D017774:Long-Term Potentiation / Q000187:drug effects / Q000235:genetics* / Q000502:physiology; D008297:Male; D035683:MicroRNAs / Q000378:metabolism*; D010879:Piperazines / Q000494:pharmacology; D051381:Rats; D017207:Rats, Sprague-Dawley; D018094:Receptors, Metabotropic Glutamate / Q000037:antagonists & inhibitors / Q000502:physiology*; D016194:Receptors, N-Methyl-D-Aspartate / Q000037:antagonists & inhibitors / Q000502:physiology*
C095756:1-aminoindan-1,5-dicarboxylic acid; D007189:Indans; D035683:MicroRNAs; D010879:Piperazines; D018094:Receptors, Metabotropic Glutamate; D016194:Receptors, N-Methyl-D-Aspartate; D003609:Dactinomycin; C050592:3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid
EMBO J. 2009 Mar 18;28(6):697-710
19197241
Neuron. 2008 Nov 6;60(3):477-82
18995822
J Neurosci. 2008 Jul 23;28(30):7555-62
18650333
Stem Cells. 2006 Apr;24(4):857-64
16357340
Nat Methods. 2006 Jan;3(1):27-9
16369549
Methods. 2008 Jan;44(1):31-8
18158130
Nat Neurosci. 2007 Dec;10(12):1513-4
17994015
Cell. 2006 Oct 6;127(1):49-58
17018276
Eur J Neurosci. 2003 Jun;17(12):2679-89
12823475
Genes Dev. 2007 Mar 1;21(5):531-6
17344415
Eur J Neurosci. 2007 Jun;25(11):3264-75
17552995
Nature. 2007 Jun 28;447(7148):1130-4
17554337
BMC Neurosci. 2006 Oct 30;7 Suppl 1:S5
17118159
Proc Natl Acad Sci U S A. 2005 Nov 8;102(45):16426-31
16260724
Eur J Neurosci. 2006 Mar;23(6):1501-11
16553613
Methods Mol Biol. 2000;132:365-86
10547847
Nat Cell Biol. 2009 Jun;11(6):705-16
19465924
Neuron. 2007 Jun 7;54(5):813-29
17553428
Cell. 2006 Jan 13;124(1):191-205
16413491
Nat Protoc. 2007;2(6):1508-14
17571058
Nature. 1989 Aug 10;340(6233):474-6
2547165
J Neurochem. 2005 Aug;94(4):896-905
16092937
Nucleic Acids Res. 2004 Jan 1;32(Database issue):D109-11
14681370
J Biol Chem. 2009 Nov 13;284(46):31498-511
19755425
Genes Dev. 2007 Aug 15;21(16):1975-82
17699746
RNA. 2007 Aug;13(8):1224-34
17592044
Neuron. 2009 Sep 24;63(6):803-17
19778509
Proc Natl Acad Sci U S A. 2008 Jul 1;105(26):9093-8
18577589
Curr Opin Neurobiol. 2006 Oct;16(5):535-9
16962314
Mol Cell. 2007 Jun 8;26(5):745-52
17540599
Mol Cell. 2007 Mar 9;25(5):635-46
17349952
Neuropharmacology. 1997 Oct;36(10):1339-54
9423922
Exp Brain Res. 2010 Jan;200(2):125-40
19690847
Brain Res Mol Brain Res. 1995 Jan;28(1):87-93
7707882
Nat Neurosci. 2009 Apr;12(4):399-408
19287386
Nat Rev Neurosci. 2006 Dec;7(12):911-20
17115073
Nat Rev Neurosci. 2008 May;9(5):387
18401345
Nature. 2006 Jan 19;439(7074):283-9
16421561
Nucleic Acids Res. 2007 Jan;35(Database issue):D668-73
17142222
J Neurosci. 2008 Dec 17;28(51):13793-804
19091970
J Neurosci. 2002 Sep 1;22(17):7453-61
12196567
Nat Rev Genet. 2008 Feb;9(2):102-14
18197166
Nat Methods. 2009 Feb;6(2):139-41
19137005
Mol Cell. 2008 Dec 5;32(5):605-15
19061636
Neural Plast. 2007;2007:26496
18301726
J Neurosci. 2007 Sep 26;27(39):10445-55
17898216
Neuroscience. 2004;123(2):507-14
14698757
Biochem Biophys Res Commun. 2008 Jul 18;372(1):24-9
18474225
Cell. 2004 Jan 23;116(2):281-97
14744438
J Neurochem. 2008 Jul;106(2):650-61
18410515
Hippocampus. 2008;18(1):48-54
17924526
Nat Cell Biol. 2009 Mar;11(3):228-34
19255566
Nucleic Acids Res. 2005 Sep 28;33(17):5394-403
16192569
Nat Rev Neurosci. 2007 Oct;8(10):776-89
17848965